Skip to content

Observation on Patients with Rheumatoid Arthritis and its Complications: a multi-center, prospective cohort study

Observation on Patients with Rheumatoid Arthritis and its Complications: a multi-center, prospective cohort study

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300069051
Enrollment
Unknown
Registered
2023-03-06
Start date
2023-03-06
Completion date
Unknown
Last updated
2023-05-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

rheumatoid arthritis

Interventions

RA group:N/A
RA with complications group:N/A

Sponsors

Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: (1) Female patients who meet the diagnostic criteria for RA and RA complications(carotid atherosclerosis, ILD, OP, AIH, MCI, depression, anxiety and thyroid dysfunction); (2) Aged above 18 years old; (3) Long-term residence in the community where the project is implemented (more than five years); (4) Those who can cooperate to complete the collection of relevant medical history and have complete data; (5) Sign the informed consent form.

Exclusion criteria

Exclusion criteria: (1)Those who cannot complete the cohort study due to other primary diseases; (2)Primary diseases that affect the outcome judgment, such as ankylosing spondylitis, lupus erythematosus, psoriatic arthritis and other autoimmune diseases; (3)Patients with mental disorders such as cognitive impairment.

Design outcomes

Primary

MeasureTime frame
death rate;survival time;incidence of RA in this corhort;

Secondary

MeasureTime frame
total cholesterol;triglyceride;High-density lipoprot;Low density lipoprote;glycosylated hemoglobin;Fasting blood glucose;Pulmonary function;Ca;phosphorus;alkaline phosphatase, ALP;osteocalcin;25-hydroxy-vitamin D;glutamic-pyruvic transaminase, ALT;Glutamic transaminase, AST;CGT;antinuclear antibodies, ANA;Abdominal ultrasound;Thyroid ultrasound;TT3;TT4;TRAb;TPOAb;TGAb;thyroid-stimulating hormone, TSH;Carotid artery ultrasound;HRCT;Bone mineral density;Hamilton anxiety scale ( HAMA);Hamilton Depression Rating Scale, HAMD;FT3;FT4;

Countries

China

Contacts

Public ContactLiang Qianqian

Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

liangqianqiantcm@126.com18917763347

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026